As we all know, the landscape of cannabis regulation is shifting dramatically. With the DEA's proposal to reclassify cannabis from a Schedule I to a Schedule III controlled substance, we find ourselves at a pivotal juncture. This blog post delves into what these changes mean for the industry, beyond the common knowledge—highlighting the deeper implications for business operations and legislative momentum.
%20(10).png)
%20(22).png)
%20(23).png)
%20(21).png)
%20(30).png)
%20(26).png)
.png)
%20(27).png)
